Tracks

Outlook Therapeutics: De-Risked Regulatory Tracks Are Lining Up (NASDAQ:OTLK)

admin2 months ago022 mins

nespix/iStock via Getty Images Outlook Therapeutics (NASDAQ:OTLK) has made significant progress in advancing the use of its drug ONS-5010, which is being developed for the treatment of patients with wet age-related macular degeneration [Wet-AMD]. The use of this anti-VEGF drug is being explored in several studies, but the company is on the right track with…

Coinbase CEO Eyes Flatcoins as Next Form of Money Tracked that Tracks Consumer Prices Like in CPI

admin8 months ago05 mins

Armstrong pointed out protocols like Truflation, Ampleforth/Spot, and Nuon that are building crucial infrastructure for the development of flatcoins in the near future. The growth of the cryptocurrency market has significantly been spearheaded by top crypto firms like exchanges, and DeFi protocols. Coinbase Global Inc (NASDAQ: COIN) has played a major role in pushing the…

Goldman Sachs BDC: 12% Yield And Re-Rating Potential (NYSE:GSBD)

VSDA: Exploring This 2.40% Yielding Monthly Paying Dividend Growth ETF

Amphastar: Profitable Pharma With Strong Growth (NASDAQ:AMPH)

RAPT Therapeutics (RAPT): Dip Following FDA Clinical Hold Creates Asymmetric Opportunity

DRLL: You Better Love Exxon And Chevron To Love This Fund (NYSE:DRLL)

Wendy’s: I Continue To Await New Developments From ’70/30 Strategy’ (NASDAQ:WEN)

Outlook Therapeutics: De-Risked Regulatory Tracks Are Lining Up (NASDAQ:OTLK)

Coinbase CEO Eyes Flatcoins as Next Form of Money Tracked that Tracks Consumer Prices Like in CPI